M4E(R2): The CTD – Efficacy
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 24, 2017
February 3, 2025
460793c4-42d9-4f9f-83c0-9ec5b1d6151d
Related Documents
Q3C Tables and List Rev 4
Guidance DocumentAugust 1, 2018Center for Drug Evaluation and Research
E8(R1) General Considerations for Clinical Studies
Guidance DocumentApril 8, 2022Center for Drug Evaluation and Research
Labeling for Biosimilar Products Guidance for Industry
Guidance DocumentJuly 18, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.